ReShape Lifesciences Inc. (36) | Business Finance (28)
Browse by Subcategory
Recent Contracts
-
Fourth Amendment to Credit Agreement, dated January 19, 2021, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd
(Filed With SEC on January 20, 2021)
-
Series G Common Stock Purchase Warrant, dated September 14, 2020, issued by the Company to Armistice Capital Master Fund Ltd
(Filed With SEC on September 15, 2020)
-
Registration Rights Agreement, dated March 25, 2020, by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on April 30, 2020)
-
Guarantee and Collateral Agreement, dated March 25, 2020, by and between the Company, ReShape Medical LLC and Armistice Capital Master Fund Ltd
(Filed With SEC on April 30, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on September 30, 2019)
-
Form of Debenture
(Filed With SEC on April 3, 2019)
-
Form of Security Agreement
(Filed With SEC on April 3, 2019)
-
Credit Facility Agreement, dated as of January 19, 2021, by and between ReShape Lifesciences Inc. and Armistice Capital Master Fund Ltd
(Filed With SEC on January 20, 2021)
-
Third Amendment to Credit Agreement, dated December 16, 2020, by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on December 22, 2020)
-
Second Amendment to Credit Agreement, dated September 14, 2020, by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on September 15, 2020)
-
Series G Common Stock Purchase Warrant, dated March 25, 2020, issued by the Company to Armistice Capital Master Fund Ltd
(Filed With SEC on April 30, 2020)
-
Credit Agreement, dated March 25, 2020, by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on April 30, 2020)
-
Amendment to Credit Agreement, dated March 31, 2020 by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on March 31, 2020)
-
Guarantee and Collateral Agreement, dated March 25, 2020, by and between the Company, ReShape Medical LLC and Armistice Capital Master Fund Ltd
(Filed With SEC on March 31, 2020)
-
Credit Agreement, dated March 25, 2020, by and between the Company and Armistice Capital Master Fund Ltd., as amended
(Filed With SEC on March 31, 2020)
-
Amendment to Series G Common Stock Purchase Warrant, dated March 25, 2020 issued by the Company to Armistice Capital Master Fund Ltd., as amended
(Filed With SEC on March 31, 2020)
-
Registration Rights Agreement, dated March 25, 2020, by and between the Company and Armistice Capital Master Fund Ltd
(Filed With SEC on March 31, 2020)
-
Series G Common Stock Purchase Warrant, dated March 25, 2020, issued by the Company to Armistice Capital Master Fund Ltd., as amended
(Filed With SEC on March 31, 2020)
-
Form of Amended and Restated Registration Rights Agreement
(Filed With SEC on September 30, 2019)
-
Form of Series F Warrant
(Filed With SEC on September 30, 2019)
-
Form of Series E Warrant
(Filed With SEC on September 30, 2019)
-
Form of Registration Rights Agreement
(Filed With SEC on June 19, 2019)
-
Form of Series C Prefunded Warrant
(Filed With SEC on June 19, 2019)
-
Form of Series B Warrant
(Filed With SEC on June 19, 2019)
-
Form of Series A Warrant
(Filed With SEC on June 19, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 19, 2019)
-
Form of Registration Rights Agreement
(Filed With SEC on April 3, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 3, 2019)